RAAJMEDI

Raaj Medisafe India financials

Market cap
₹148 Cr

Quarterly results

Q1 FY27: revenue up 86.1%, net profit up 34.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue11 15 24 16 18 +69%21 +42%25 +3%29 +86%
EBITDA2 2 3 3 3 +59%4 +66%3 −13%4 +55%
Net profit1 1 3 1 2 +78%2 +83%-3 −193%2 +35%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +14.8% 1Y

₹70₹80₹90₹100Sept 25Oct 25Dec 25Jan 26Mar 26May 26Jun 26Aug 26

1Y: ₹87 on 4 Sept 2025 → ₹99.85. High ₹101.9 (2 Sept 2026), low ₹64.78 (29 Dec 2025).

Financials, as filed

Revenue grew 36.0% a year over 2 years, FY24 to FY26. Operating margin narrowed to 14.7%.

Year endingFY24FY25FY26
Revenue₹43 Cr₹61 Cr₹80 Cr
Operating profit₹7 Cr₹9 Cr₹12 Cr
Operating margin15.3%14.5%14.7%
Interest₹2 Cr₹2 Cr₹4 Cr
Depreciation₹1 Cr₹1 Cr₹2 Cr
Net profit₹3 Cr₹6 Cr₹2 Cr
Net margin7.7%10.6%2.3%
Cash from operations₹4 Cr₹-0 Cr₹4 Cr
Free cash flow₹-7 Cr₹-13 Cr₹-30 Cr
ROCE19.6%15.0%11.9%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹13 Cr₹16 Cr
Reserves₹-10 Cr₹-7 Cr₹-3 Cr₹-0 Cr₹16 Cr₹30 Cr
Borrowings₹13 Cr₹13 Cr₹16 Cr₹26 Cr₹52 Cr₹65 Cr
Other liabilities₹2 Cr₹2 Cr₹3 Cr₹5 Cr₹8 Cr₹10 Cr
Total liabilities₹17 Cr₹20 Cr₹26 Cr₹41 Cr₹89 Cr₹121 Cr
Fixed assets₹7 Cr₹9 Cr₹9 Cr₹11 Cr₹29 Cr₹39 Cr
Capital work in progress₹2 Cr₹0 Cr₹2 Cr₹10 Cr₹16 Cr₹27 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹8 Cr₹10 Cr₹15 Cr₹20 Cr₹44 Cr₹55 Cr
Total assets₹17 Cr₹20 Cr₹26 Cr₹41 Cr₹89 Cr₹121 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, promoters trimmed −14.37 pp while the public added +14.37 pp. The shareholder count shrank 4% to 7,783.

Promoters
59.1%
Public
40.9%

Since Jun 2025

  • Promoters −14.37 pp
  • Public +14.37 pp

How it drifted, 12 quarters

Over this window promoters fell from 73.5% to 59.1% — −14.4 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 73.5%, Public 26.6%.Dec '23: Promoters 73.5%, Public 26.5%.Mar '24: Promoters 73.5%, Public 26.6%.Jun '24: Promoters 73.5%, Public 26.6%.Sep '24: Promoters 73.5%, Public 26.6%.Dec '24: Promoters 73.5%, Public 26.6%.Mar '25: Promoters 73.5%, Public 26.6%.Jun '25: Promoters 73.5%, Public 26.6%.Sep '25: Promoters 73.8%, Public 26.2%.Dec '25: Promoters 73.8%, Public 26.2%.Mar '26: Promoters 73.8%, Public 26.2%.Jun '26: Promoters 59.1%, Public 40.9%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 12 holders trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Raaj Medisafe India Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Sushen Remedies Private Limited 15.40%−3.84 pp
Baldeo Mangilal 12.90%−3.21 pp
Anand Bangur 9.04%−2.25 pp
Vishnu Jajoo 4.94%−1.23 pp
Vyanktesh Securities Private Limited 3.41%−0.85 pp
Dinesh Patel 3.32%newly disclosed
Seema Patel 3.32%newly disclosed
Arpit Packaging Private Limited 3.02%−0.75 pp
Shweta Jajoo 2.92%−0.73 pp
Govind Maheshwari 2.78%newly disclosed
Lifepulse Medtech Private Limited 2.44%newly disclosed
Arpit Bangur 2.03%−0.51 pp

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.